Robert J. Konrad
Lilly Research Laboratories
Eli Lilly and Company
Indianapolis
IN 46285
USA
Name/email consistency: high
- Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents. Konrad, R.J., Troutt, J.S., Cao, G. Lipids. Health. Dis (2011)
- The role of O-linked protein glycosylation in beta-cell dysfunction. Konrad, R.J., Kudlow, J.E. Int. J. Mol. Med. (2002)
- Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. Konrad, R.J., Tolar, J.F., Hale, J.E., Knierman, M.D., Becker, G.W., Kudlow, J.E. Biochem. Biophys. Res. Commun. (2001)